Empowering the patient voice

Bridging innovation and access in rare disease care

For the 30 million people across Europe living with a rare disease, the journey to diagnosis, treatment and ongoing care is often long and fragmented. Barriers such as limited treatment options, uneven access and unrecognised mental health needs highlight a critical gap between innovation and equitable care.

Increasingly, the patient voice is being recognised as a powerful force in closing this gap. By placing patients and their lived experiences at the centre of drug development, clinical practice and policy, stakeholders can build systems that are not only scientifically sound but also responsive to real-world needs.

In this white paper, we explore:

• How patient perspectives are shaping regulatory and reimbursement frameworks across Europe

• The importance of integrating mental health into rare disease care models

• The evolving role of nurses and patient support programmes in driving trust, adherence and better outcomes

• Practical strategies to reduce disparities in access and build more equitable healthcare pathways

Download this free white paper for clinical and strategic insights on how patient engagement can transform rare disease care in Europe.